![Standish M. Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Standish M. Fleming
Fondateur chez
Forward Ventures Services LLC
Profil
Standish M.
Fleming is the founder and the Founding Managing Partner of Forward Ventures Services LLC, which was founded in 1993.
He is currently the Director at CONNECT since 2011.
Mr. Fleming has also held former positions as a Director at Kémia, Inc., Acorda Therapeutics, Inc., Nereus Pharmaceuticals, Inc., Gryphon Therapeutics, Inc., AriZeke Pharmaceuticals, Inc., and Viracta Subsidiary, Inc. Additionally, he served as an Independent Director at Ambit Biosciences Corp.
from 2001 to 2014.
Mr. Fleming obtained his undergraduate degree from Amherst College in 1969 and an MBA from UCLA Anderson School of Management in 1986.
Postes actifs de Standish M. Fleming
| Sociétés | Poste | Début |
|---|---|---|
Forward Ventures Services LLC
 Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements. | Fondateur | 17/11/2010 |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Directeur/Membre du Conseil | 02/11/2010 |
Anciens postes connus de Standish M. Fleming
| Sociétés | Poste | Fin |
|---|---|---|
| AMBIT BIOSCIENCES CORP | Directeur/Membre du Conseil | 10/11/2014 |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutics for cancer, inflammatory, and infectious diseases | Directeur/Membre du Conseil | 29/04/2013 |
Gryphon Therapeutics, Inc.
 Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces protein therapeutics | Directeur/Membre du Conseil | 09/12/2009 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Directeur/Membre du Conseil | - |
AriZeke Pharmaceuticals, Inc.
 AriZeke Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Delivers therapeutic proteins and genes | Directeur/Membre du Conseil | - |
Formation de Standish M. Fleming
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Kémia, Inc.
 Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapeutics for cancer, inflammatory, and infectious diseases | Commercial Services |
Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces protein therapeutics | Health Technology |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Ventures Services LLC
Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements. | Finance |
AriZeke Pharmaceuticals, Inc.
AriZeke Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Delivers therapeutic proteins and genes | Health Technology |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
